By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Aureus Pharma said today that it will participate in the Biointelligence R&D Programme, a €118.2 million ($159.8 million) European consortium focused on promoting the use of systemic modeling and simulation tools for biomedical databases.

The Paris-based company said that it could receive an estimated €3.5 million for its participation in the program, under which it will contribute knowledge management and content development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.